COVID-19 mortality in cirrhosis is determined by cirrhosis-associated comorbidities and extrahepatic organ failure: Results from the multinational LEOSS registry.
Jonathan Frederik BrozatFrank HansesMartina HaelbergerMelanie StecherMichael DreherLukas TomettenMaria M RuethrichJanne J VehreschildChristian TrautweinStefan BorgmannMaria J G T VehreschildCarolin E M JakobAndreas StallmachKai WilleKerstin HellwigNora IsbernerPhilipp A ReukenFabian GeislerJacob NattermannKaren Schmidtnull nullPublished in: United European gastroenterology journal (2022)
In immunologically naïve patients with cirrhosis, mortality from wild-type SARS-CoV-2 and the alpha variant is high and is largely determined by cirrhosis-associated comorbidities and extrahepatic organ failure.